Phase IIa proof-of-concept trial of CC8464 in patients with peripheral neuropathic pain

Trial Profile

Phase IIa proof-of-concept trial of CC8464 in patients with peripheral neuropathic pain

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs CC 8464 (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2016 According to a Chromocell media release, first patient is dosed with CC8464 for the management of neuropathic pain.
    • 13 Oct 2016 Status changed from planning to recruiting, according to a Chromocell media release.
    • 06 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top